Genetic epidemiology of osteoarthritis: Recent developments and future directions

Current Opinion in Rheumatology

Volumn 25, Issue 2, 2013, Pages 192-197

  Hochberg, Marc C ^a   Yerges Armstrong, Laura ^a   Yau, Michelle ^a   Mitchell, Braxton D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

endophenotypes; genes; osteoarthritis; sequencing; single nucleotide polymorphisms

Indexed keywords

FILAMIN A; HISTONE H3; SCLEROPROTEIN; TANEZUMAB;

ARTERIAL WALL THICKNESS; ARTHRALGIA; BONE DYSPLASIA; CARTILAGE CELL; CHROMOSOME 13Q; CORONARY ARTERY DISEASE; ENDOPHENOTYPE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; HAND OSTEOARTHRITIS; HAPLOTYPE; HIP OSTEOARTHRITIS; HUMAN; JOINT PROSTHESIS; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS (TOPIC); METHYLATION; MISSENSE MUTATION; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY;

ARTHRALGIA; BODY MASS INDEX; BONE DENSITY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OSTEOARTHRITIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84873408349     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835cfb8e     Document Type: Review

References (43)

1. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58:26-35.
2. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137-162.
3. Hochberg MC, Altman RD, April KT, et al. American College Of Rheumatology 2012 recommendations forthe use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64:465-474.
4. Valdes AM, Spector TD. Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol 2011; 7:23-32.
5. Van Meurs JB, Uitterlinden AG. Osteoarthritis year 2012 in review: genetics and genomics. Osteoarthritis Cartilage 2012; 20: 1470-1476.
6. Kellgren JH, Lawrence JS, Bier F. Genetic factors in generalized osteo-arthrosis. Ann Rheum Dis 1963; 22:237-255.
7. Spector TD, Cicuttini F, Baker J, et al. Genetic influences on osteoarthritis in women: a twin study. BMJ 1996; 312:940-943.
8. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med 2005; 7:1-12.
9. Panoutsopoulou K, Southam L, Elliott KS, et al. Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis 2011; 70:864-867.
10. Valdes AM, Evangelou E, Kerkhof HJ, et al. The GDF5 rs143383 polymorph-ism is associated with osteoarthritis of the knee with genome-wide statistical significance. Ann Rheum Dis 2011; 70:873-875.
11. Evangelou E, Valdes AM, Kerkhof HJ, et al. Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis 2011; 70:349-355.
12. Day-Williams AG, Southam L, Panoutsopoulou K, et al. A variant in MCF2L is associated with osteoarthritis. Am J Hum Genet 2011; 89:446-450.
13. Miyamoto Y, Mabuchi A, Shi D, et al. Afunctional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007; 39:529-533.
14. Chapman K, Takahashi A, Meulenbelt I, et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet 2008; 17:1497-1504.
15. Evangelou E, Chapman K, Meulenbelt I, et al. Large-scale analysisofassocia-tion between GDF5 and FRZBvariantsand osteoarthritisof the hip, knee, and hand. Arthritis Rheum 2009; 60:1710-1721.
16. Kerkhof HJ, Lories RJ, Meulenbelt I, et al. A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum 2010; 62:499-510.
17. Cornelis FM, Luyten FP, Lories RJ. Functional effectsofsusceptibilitygenes in osteoarthritis. Discov Med 2011; 12:129-139.
18. Reynard LN, Bui C, Canty-Laird EG, et al. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011; 20:3450-3460.
19. Dodd AW, Rodriguez-Fontenla C, Calaza M, et al. Deep sequencing of GDF5 reveals the absence of rare variants at this important osteoarthritis susceptibility locus. Osteoarthritis Cartilage 2011; 19: 430-434.
20. Dodd AW, Syddall CM, Loughlin J. A rare variant in the osteoarthritis-associated locus GDF5 is functional and reveals a site that can be manipu-lated to modulate GDF5 expression. Eur J Hum Genet 2012. doi: 10. 1038/ejhg. 2012. 197. [Epub ahead of print].
21. Raine EV, Wreglesworth N, Dodd AW, et al. Gene expression analysis reveals HBP1 as a key target for the osteoarthritis susceptibility locus that maps to chromosome 7q22. Ann Rheum Dis 2012; 71:2020-2027.
22. Chapman K, Valdes AM. Genetic factors in OA pathogenesis. Bone 2012; 51:258-264.
23. Attur M, Wang HY, Kraus VB, et al. Radiographic severity of knee osteoar-thritis is conditional on interleukin 1 receptor antagonist gene variations. Ann Rheum Dis 2010; 69:856-861.
24. Kerkhof HJ, Doherty M, Arden NK, et al. Large-scale meta-analysis of inter-leukin-1 betaand interleukin-1 receptor antagonistpolymorphisms on riskof radiographic hip and knee osteoarthritis and severity of knee osteoarthritis. Osteoarthritis Cartilage 2011; 19:265-271.
25. Sanna S, Li B, Mulas A, et al. Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet 2011; 7:e1002198.
26. Southam L, Rodriguez-Lopez J, Wilkins JM, et al. An SNP in the 5'-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet 2007; 16:2226-2232.
27. van de Laar IM, Oldenburg RA, Pals G, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoar-thritis. Nat Genet 2011; 43:121-126.
28. Regalado ES, Guo DC, Villamizar C, et al. Exomesequencing identifiesSMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 2011; 109:680-686.
29. van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet 2012; 49:47-57.
30. Mu SC, Lin YJ, Liu HC, et al. A mutation in cartilage oligomeric matrix protein (COMP) causes early-onset osteoarthritis in a large kindred study. Ann Hum Genet 2011; 75:575-583.
31. Min BJ, Kim N, Chung T, et al. Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type. Am J Hum Genet 2011; 89:760-766.
32. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet 2010; 375:1525-1535.
33. Castano Betancourt MC, Cailotto F, Kerkhof HJ, et al. Genome-wide associa-tion and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci USA 2012; 109:8218-8223.
34. Lynch JA, Parimi N, Chaganti RK, et al. The association of proximal femoral shape and incident radiographic hip OA in elderly women. Osteoarthritis Cartilage 2009; 17:1313-1318.
35. Waarsing JH, Kloppenburg M, Slagboom PE, et al. Osteoarthritis suscept-ibility genes influence the association between hip morphology and osteoar-thritis. Arthritis Rheum 2011; 63:1349-1354.
36. Baker-Lepain JC, Lynch JA, Parimi N, et al. Variantalleles of the Wntantagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. Arthritis Rheum 2012; 64:1457-1465.
37. Peters MJ, Broer L, Willemen HL, et al. Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15. 2 region. Ann Rheum Dis 2012. [Epub ahead of print]
38. Bouhouche A, Benomar A, Bouslam N, et al. Mutation in theepsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 2006; 43:441-443.
39. Sorge RE, Trang T, Dorfman R, et al. Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med 2012; 18:595-599.
40. Hoeven TA, Kavousi M, Clockaerts S, et al. Association ofatherosclerosiswith presenceand progression of osteoarthritis: the Rotterdam Study. Ann Rheum Dis 2012. [Epub ahead of print]
41. Elliott KS, Chapman K, Day-Williams A, et al. Evaluation ofthegeneticoverlap between osteoarthritis with body mass index and height using genome-wide association scan data. Ann Rheum Dis 2012. [Epub ahead of print]
42. Chaganti RK, Parimi N, Lang T, et al. Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group. Osteoporos Int 2010; 21:1307-1316.
43. Ritchie MD, Denny JC, Crawford DC, et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010; 86:560-572.